Private equity firm Arlington Capital Partners has acquired Avalign Technologies from RoundTable Healthcare Partners.
Avalign is a manufacturer of implants and instruments, specialty instrumentation, cutting tools, and cases and trays to the orthopedic medical device and specialty surgical markets. Avalign offers its OEM partners a broad portfolio of manufacturing solutions and extensive engineering design, development, and project management capabilities from concept to launch. Avalign has an established reputation for consistent and sophisticated quality systems, flexible capacity capabilities, and superior customer service.
Matt Altman (pictured), a Partner at Arlington Capital, says: “Avalign is an established leader in the large and growing orthopedic precision manufacturing market. Recognised across the industry for its superior engineering and manufacturing capabilities, Avalign provides significant value to its OEM partners through design improvement, speed to market acceleration and cost reductions. We look forward to partnering with the highly talented Avalign management team to support the Company through its next phase of growth.”
Forrest Whittaker, CEO of Avalign, says: “We are extremely pleased to be partnering with Arlington Capital. Avalign is committed to improving patient outcomes by providing best-in-class medical devices through our industry leading end to end capabilities. We believe that Arlington Capital, which has deep expertise and an impressive track record in healthcare and precision manufacturing, is the ideal partner to help us achieve our goals. We would also like to thank RoundTable Healthcare Partners for all of their support and partnership to date.”
Malcolm Little, a Vice President at Arlington Capital, says: “We are delighted to partner with the Avalign team. They have built a world class enterprise that we believe has an excellent opportunity for continued growth.”
